UK parliamentary committee beats medical technology uptake report deadline
This article was originally published in Clinica
Executive Summary
The House of Commons select committee on health met today to discuss its report on "The use of new medical technologies within the NHS", with a view to programming its approval and publication around the imminent dissolution of Parliament ahead of the May 5 general election, Clinica has learnt. A decision will not be announced before the end of the day, but the Committee is aiming to publish, a clerk said.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.